| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/03/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 17/03/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Unavailable | Manufacturing | 17/03/2025 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| cabergoline | Tablet, uncoated | 2 mg | Resolved | Available | Manufacturing | 17/03/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| fluticasone furoate | Spray, suspension | 27.5 microgram | Resolved | Available | Unexpected increase in consumer demand | 14/03/2025 |
| fluconazole | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 14/03/2025 |
| fluconazole | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 14/03/2025 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 14/03/2025 |
| furosemide | Injection, solution | 20 mg | Anticipated | Available | Manufacturing | 14/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/03/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Resolved | Available | Unexpected increase in consumer demand | 14/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 14/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| tadalafil | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 14/03/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Anticipated | Available | Manufacturing | 14/03/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 14/03/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| daptomycin | Injection, powder for | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 14/03/2025 |
| daptomycin | Inhalation, powder for | 350 mg | Current | Limited Availability | Manufacturing | 14/03/2025 |
| naproxen | Tablet | 500 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Resolved | Available | Manufacturing | 14/03/2025 |
| bicisate dihydrochloride | Injection, powder for | .9 mg | Anticipated | Available | Manufacturing | 14/03/2025 |
| estradiol~dydrogesterone | Tablet, film coated | 2 mg~10 mg | Current | Unavailable | Manufacturing | 14/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/03/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Anticipated | Available | Manufacturing | 14/03/2025 |
| alprostadil | Injection, powder for | 20 microgram/mL | Anticipated | Available | Unexpected increase in consumer demand | 14/03/2025 |
| gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 13/03/2025 |
| flecainide acetate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 13/03/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 13/03/2025 |
| dexamethasone~gramicidin~framycetin sulfate | Ear Drops | .5 mg/mL~.05 mg/mL~5 mg/mL | Current | Limited Availability | Manufacturing | 13/03/2025 |
| fentanyl | Drug delivery system, transdermal | 8.4 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 13/03/2025 |
| fentanyl | Drug delivery system, transdermal | 16.8 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Anticipated | Available | Manufacturing | 13/03/2025 |
| glycopyrronium bromide | Injection, solution | .2 mg/mL | Resolved | Available | Manufacturing | 13/03/2025 |
| donepezil hydrochloride | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 13/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/03/2025 |
| Belimumab | Injection, powder for | 120 mg | Anticipated | Available | Manufacturing | 13/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| praziquantel | Tablet, film coated | 600 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 13/03/2025 |
| chloramphenicol | Eye Drops | 5 mg/mL | Resolved | Available | Manufacturing | 13/03/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| quetiapine fumarate | Tablet, film coated | 28.784 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| levothyroxine sodium | Tablet | 200 microgram | Resolved | Available | Manufacturing | 13/03/2025 |
| salmeterol xinafoate~fluticasone propionate | Inhalation, powder for | 72.5 microgram/actuation~100 microgram/actuation | Current | Limited Availability | Unexpected increase in consumer demand | 13/03/2025 |
| escitalopram oxalate | Tablet, film coated | 25.548 mg | Current | Limited Availability | Manufacturing | 13/03/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Current | Limited Availability | Manufacturing | 13/03/2025 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate | Injection, solution | 2.64 mg/mL~4.5 microgram/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 13/03/2025 |
| nebivolol hydrochloride | Tablet | 10.9 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 13/03/2025 |
| rivaroxaban | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 13/03/2025 |
| sitagliptin fumarate | Tablet, film coated | 32.124 mg | Resolved | Available | Manufacturing | 13/03/2025 |
| rivaroxaban | Tablet, film coated | 2.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/03/2025 |
| framycetin sulfate~dexamethasone~gramicidin | Ear Drops | 5 mg/mL~.5 mg/mL~.05 mg/mL | Current | Limited Availability | Manufacturing | 13/03/2025 |
| citalopram hydrobromide | Tablet, film coated | 24.98 mg | Resolved | Available | Manufacturing | 13/03/2025 |
| primidone | Tablet, uncoated | 250 mg | Anticipated | Available | Manufacturing | 12/03/2025 |
| heparin sodium | Injection, solution | 5000 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 12/03/2025 |
| venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 12/03/2025 |
| hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet | 12.5 mg~6.944 mg~20 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil | Tablet | 6.944 mg~12.5 mg~40 mg | Current | Limited Availability | Manufacturing | 12/03/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 20.791 mg~10 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| rizatriptan benzoate | Wafer | 14.53 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 12/03/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 12/03/2025 |
| cisplatin | Injection, concentrated | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 12/03/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 600000 USP Unit | Current | Unavailable | Manufacturing | 12/03/2025 |
| solifenacin succinate | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| solifenacin succinate | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| aciclovir | Injection, solution | 25 mg/mL | Resolved | Available | Manufacturing | 12/03/2025 |
| dasatinib propylene glycol | Tablet, film coated | 58 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| dasatinib propylene glycol | Tablet, film coated | 81.2 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| dasatinib propylene glycol | Tablet, film coated | 116 mg | Current | Unavailable | Manufacturing | 12/03/2025 |
| mycophenolate sodium | Tablet, enteric coated | 384.7 mg | Anticipated | Available | Manufacturing | 12/03/2025 |
| mupirocin calcium | Cream | 21.5 mg/g | Resolved | Available | Manufacturing | 12/03/2025 |
| melatonin | Capsule, hard | 3 mg | Current | Limited Availability | Unexpected increase in consumer demand | 12/03/2025 |
| balsalazide sodium | Capsule | 750 mg | Current | Limited Availability | Manufacturing | 12/03/2025 |
| alendronate sodium trihydrate | Tablet, uncoated | 91.35 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| oxytocin | Injection, solution | 10 IU/mL | Current | Unavailable | Unexpected increase in consumer demand | 11/03/2025 |
| aripiprazole | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 11/03/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 11/03/2025 |
| risperidone | Tablet, film coated | 4 mg | Current | Unavailable | Manufacturing | 11/03/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| isotretinoin | Capsule, soft | 10 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| candesartan cilexetil | Tablet, uncoated | 4 mg | Resolved | Available | Manufacturing | 11/03/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Current | Unavailable | Manufacturing | 11/03/2025 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 11/03/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 11/03/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Current | Unavailable | Manufacturing | 11/03/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 25 mg~300 mg | Current | Unavailable | Manufacturing | 11/03/2025 |
| atomoxetine hydrochloride | Capsule, hard | 114 mg | Resolved | Available | Manufacturing | 11/03/2025 |
| fluconazole | Capsule, hard | 200 mg | Anticipated | Available | Manufacturing | 11/03/2025 |
| olanzapine | Tablet, uncoated | 5 mg | Current | Unavailable | Manufacturing | 11/03/2025 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Unavailable | Unexpected increase in consumer demand | 11/03/2025 |
| melatonin | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 11/03/2025 |
| heparin sodium | Injection, solution | 1000 IU/mL | Current | Limited Availability | Manufacturing | 11/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Limited Availability | Manufacturing | 10/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Limited Availability | Manufacturing | 10/03/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Limited Availability | Manufacturing | 10/03/2025 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 10/03/2025 |
| irinotecan hydrochloride trihydrate | Injection, concentrated | 500 mg | Current | Limited Availability | Manufacturing | 10/03/2025 |
| carboplatin | Injection, solution | 10 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 10/03/2025 |
2025年3月17日